Recipharm bolsters development business with new appointments in the US and Europe

CDMO appoints Anders Högdin and Aaron Small to lead the growth of its pharmaceutical development services business in the US and Europe.

Since forming in Sweden in 1995, Recipharm has experienced strong year-on-year growth and is now operating from 20+ sites across 10 countries. In addition to its manufacturing services offering, Recipharm delivers pharmaceutical development services from the early discovery phase to supply of clinical trial materials from facilities in Sweden, Italy, France, Israel and the US. Parallel to these new appointments, Recipharm has strengthened the respective sales team to create focus on customer management and new business opportunities.

Based in Stockholm, Sweden, Anders Högdin will head the business development and sales team within development services in Europe. Anders has a MSc in chemistry and a PhD in organic chemistry from Uppsala University. Before joining Recipharm in 2015, he was employed at Syntagon, APL and OnTarget Chemistry in various roles.

Focused on driving the growth of the Recipharm’s North American business, Aaron Small will work in close contact with the Recipharm facility in Research Triangle Park, North Carolina. Aaron has a BSc in marketing and a Master of Business Administration and has been part of Recipharm’s business management function since 2012.

Commenting on the appointments, Carl-Johan Spak, Executive Vice President, Global Technologies said: “Over the past year, Recipharm’s development business has continued to expand, with the integration of new facilities, technologies and capabilities. The new North American sales organisation will be extremely important for Recipharm as it will enable the company to attract US customers to its extensive network of development and manufacturing facilities outside of the US”.

“We are very pleased to have such skilled, ambitious and enthusiastic professionals like Anders and Aaron to lead these two sales teams. Their contributions will be extremely valuable in the development of our business in offering new and existing customers access to our world class contract development and manufacturing services.”